EUVIMEDEUVIMED entdecken
Crossref

Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics

Rocco Trisolini, Valeria Cetoretta, Giovanni Sotgiu, Alessandra Cancellieri, Mariangela Puci, Marta Viscuso, Vanina Livi, Massimiliano Cani, Giovanni Scambia, Federico Cappuzzo, Emilio Bria, Silvia Novello

Clinical Lung Cancer · 2025

DOI: 10.1016/j.cllc.2025.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025. Verfasst von Rocco Trisolini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Pulmonology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Hearth, Rome, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Lymphatic Metastasis, Lymph Nodes, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prevalence of supraclavicular lymph nodes metastases (SNM) in advanced lung cancer has not been systematically evaluated, nor has then been a comparison of demographic, clinical, or molecular characteristics between patients with and without SNM. METHODS: In this prospective cohort study, the presence of SNM was evaluated using imaging studies (CT, PET, neck ultrasonography) in patients with suspected advanced lung cancer referred for biopsy aimed at diagnosis and molecular profiling. Ultrasound-guided biopsy confirmed or excluded metastatic involvement when suspicious supraclavicular nodes were identified. We assessed the prevalence of SNM and compared the demographic, clinicopathologic and molecular characteristics of patients with and without SNM. RESULTS: Among the 348 patients with advanced lung cancer, 94 (27%) had SMN. SMN was more common in small cell lung cancer (24/48, 50%) and adenocarcinoma (61/248, 24.6%) than in squamous cell carcinoma (4/35, 11.4%). Compared to patients without SMN, those with SMN were more likely to have small-cell lung cancer, N2/3 disease (97.9 vs. 83.9%, P < .0001), liver metastases (29.8% vs. 16.1% P = .006), and metastases to less common sites (33.7% vs. 14.1%, P < .0001). The prevalence of genomic alterations and PD-L1 expression did not differ between biopsy samples obtained from SNM and those from the primary tumor or other metastatic sites. CONCLUSION: SNM is common in patients with advanced small-cell lung cancer and adenocarcinoma. Ultrasound-guided biopsy of SNM is a simple and relatively inexpensive method for obtaining adequate tissue samples for diagnosis and comprehensive molecular profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsLymphatic MetastasisLymph NodesSmall Cell Lung CarcinomaCarcinoma, Squamous CellHumansFemaleMaleMiddle AgedAgedPrevalenceProspective StudiesAdultAged, 80 and overFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

AdenocarcinomaNext generation sequencingProgrammed cell death ligand-1Small-cell lung cancerUltrasound guided-biopsy

Autor:innen und Institutionen

  • Interventional Pulmonology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Hearth, Rome, Italy.
  • Interventional Pulmonology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Hearth, Rome, Italy; Department of Oncology, University of Turin, Azienda Ospedaliero-Univers…
  • Clinical Epidemiology and Medical Statistics Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
  • Pathology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Interventional Pulmonology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Hearth, Rome, Italy; Pulmonology Division, Fondazione Policlinico Universitario A. Gemelli IR…
  • Department of Oncology, University of Turin, Azienda Ospedaliero-Universitaria San Luigi, Turin, Italy.

Zitieren

APA

Trisolini, R., Cetoretta, V., Sotgiu, G., Cancellieri, A., Puci, M., Viscuso, M., Livi, V., Cani, M., Scambia, G., Cappuzzo, F., Bria, E., & Novello, S. (2025). Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.02.003

Vancouver

Trisolini R, Cetoretta V, Sotgiu G, Cancellieri A, Puci M, Viscuso M, et al. Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics. Clinical Lung Cancer. 2025. doi:10.1016/j.cllc.2025.02.003

BibTeX
@article{Trisolini2025,
  author = {Trisolini, Rocco and Cetoretta, Valeria and Sotgiu, Giovanni and Cancellieri, Alessandra and Puci, Mariangela and Viscuso, Marta and Livi, Vanina and Cani, Massimiliano and Scambia, Giovanni and Cappuzzo, Federico and Bria, Emilio and Novello, Silvia},
  title = {Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics},
  journal = {Clinical Lung Cancer},
  year = {2025},
  doi = {10.1016/j.cllc.2025.02.003}
}
Kostenlos starten →